Because of its composition, Aminoplasmal Hepa 10% should be administered to patients with concomitant renal insufficiency only after individual benefit/risk assessment.
The dose should be adjusted according to the serum urea and creatinine concentrations.
Caution is also to be exercised in patients with increased serum osmolarity.